Monthly Publications

Leveraging Mycobacterium tuberculosis Rv1507A Protein for Improved Immunogenicity in Mycobacterium bovis BCG Vaccine. Naqvi N, Alam A, Shariq M, Ahuja Y, Mitra DK, Hasnain SE, Ehtesham NZ. Immunology. 2026 Mar;177(3):526-539. doi: 10.1111/imm.70063. Epub 2025 Nov 8. Controlled human infection with Mycobacterium tuberculosis: practical considerations for clinical trials. Seshadri C, Flynn JL, Maiello P, Schnappinger D,…

Development of Exclusive and Efficient Intranasal or Pulmonary Dosing Methods for a Dry Powder Tuberculosis Vaccine for Use in Nonhuman Primates. Chen JZ, Tavernini S, Aisenstat M, Duong K, Wang H, McCollum J, McClary WD, Gerhardt A, Kuehl PJ, Martin AR, Vehring R, Fox CB. J Aerosol Med Pulm Drug Deliv. 2026 Feb;39(1):11-21. doi: 10.1177/19412711251383716.…

T cell-macrophage interactions in tuberculosis: What we’ve got here is failure to communicate. Mortensen R, Arlehamn CSL, Coler RN, Gerner MY, Goletti D, Lewinsohn DA, Modlin RL, Musvosvi M, Rengarajan J, Urdahl KB, Walzl G, Behar SM, Barber DL; Collaboration for Tuberculosis Vaccine Discovery – Conventional T cells Research Community, Gates Foundation. J Intern Med.…

Characterization and anti-tuberculosis effects of γδ T cells expanded and activated by Mycobacterium tuberculosis heat-resistant antigen. Guo F, Song Y, Dong S, Wei J, Li B, Xu T, Wang H. Virulence. 2025 Dec;16(1):2462092. doi: 10.1080/21505594.2025.2462092. Epub 2025 Feb 8.   RNA vaccines: The dawn of a new age for tuberculosis? Li J, Liu D, Li X, Wei J, Du W, Zhao A, Xu M. Hum Vaccin Immunother. 2025…

Finding and filling the knowledge gaps in mechanisms of T cell-mediated TB immunity to inform vaccine design. Lefrançais E, Hudrisier D, Neyrolles O, Behar SM, Ernst JD. Nat Rev Immunol. 2025 Nov;25(11):798-815. doi: 10.1038/s41577-025-01192-z. Epub 2025 Jun 13.   Immunogenicity, biodistribution, and toxicology evaluation of Mycobacterium tuberculosis ag85a plasmid DNA in cynomolgus monkeys, mice and guinea…